Le Lézard
Classified in: Transportation, Science and technology
Subjects: LEG, EGV, POL, PSF

SAFE Act Brings Driver Monitoring Regulations to Forefront on US Transportation Conversation


TEL AVIV, Israel, July 7, 2020 /PRNewswire/ -- Eyesight Technologies, an AI computer vision solutions leader, reacted today after Senators Edward Markey (D-Mass.) and Richard Blumenthal (D- Conn.) introduced the ''Stay Aware For Everyone" (SAFE) Act of 2020' to the United States Congress as part of four bills to reduce accidents and improve automotive safety.

Accounting for an estimated 80% of all car accidents and 25% of accident-related fatalities, distracted driving is one of the greatest threats on the road today. The SAFE act will require the United States Department of Transportation to conduct research into the use of Driver Monitoring Solutions (DMS) to reduce accidents, driver disengagement, and driver complacency due to automation. The bill would also require the department to issue a final ruling to mandate the installation of driver monitoring systems in all new passenger vehicles within two years of the ruling.

"The SAFE Act is a major breakthrough for automobile safety in the United States," said David Tolub, CEO of Eyesight Technologies. "With the EU already mandating the need for DMS and vital ADAS by 2022, the SAFE Act is the first time the United States government has moved on this level to look at how technology can protect drivers from the danger of distractions and drowsiness behind the wheel. DMS alongside ADAS are crucial to keeping our roads safe and Eyesight Technologies is committed to bringing these technologies together for that purpose."

Eyesight Technologies has created three main solutions related to driver and passenger safety and experience inside the vehicle. Driver Sense, the company's driver monitoring system (DMS), utilizes AI and computer vision to detect signs of driver drowsiness or distraction, as well as monitoring for dangerous actions such as the improper wearing of a seatbelt, holding of a cellphone and smoking behind the wheel. Fleet Sense ? is the company's aftermarket solution, providing driver monitoring solutions for fleets and telematics system providers. Finally, Cabin Sense, the company's occupancy monitoring system, monitors the car's interior, including passengers and objects left behind, to create a safer and personalized in-car environment.

To see the full regulation please visit: https://www.markey.senate.gov/imo/media/doc/SAFE%20Act.pdf

About Eyesight

Eyesight Technologies is a leader in creating intelligent sensing solutions that use edge-based computer vision and AI for safer and better driving experiences. The company focuses on the automotive in-cabin environment, offering DriverSense - driver monitoring system, CabinSense - occupancy monitoring systems and FleetSense - a driver monitoring aftermarket solution for fleets. Over a decade of research and development stand behind the company's market-leading computer vision technology, with dozens of patents and many more pending.

Eyesight Technologies is constantly pushing the boundaries of what intelligent sensing solutions can see and accomplish ? to make driving a better and safer experience.

Media Contact
Lazer Cohen
[email protected]
+1 347-753-8256

SOURCE Eyesight Technologies


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: